BRIEF published on 01/23/2026 at 07:05, 9 months 14 days ago BB Biotech AG Reports Significant Profit for 2025 Investment Company BB Biotech AG Drug Developers 2025 Profit Share Price Development
BRIEF published on 01/23/2026 at 07:05, 9 months 14 days ago BB Biotech Reports Strong Preliminary 2025 Results and Dividend Proposal Dividend Proposal Share Performance BB Biotech Biotech Investment 2025 Financial Results
PRESS RELEASE published on 01/23/2026 at 07:00, 9 months 14 days ago EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit BB Biotech AG closes the 2025 fiscal year with a profit of approximately CHF 578 million, reflecting share price development. Full report on Feb 20, 2026 BB Biotech AG Profit 2025 Fiscal Year Share Price Development CHF 578 Million
PRESS RELEASE published on 01/23/2026 at 07:00, 9 months 14 days ago BB Biotech: Preliminary full-year 2025 results and dividend proposal BB Biotech AG reports strong full-year 2025 results with +34.2% total return in CHF, +37.0% in EUR, and +53.7% in USD, proposes dividend of CHF 2.25 per share at AGM on March 19, 2026 Dividend Proposal Stock Market Full-year Results BB Biotech AG 2025 Performance
BRIEF published on 10/28/2025 at 13:20, 1 year ago BB Biotech Outperforms with Strong Q3 2025 Results Biotech Sector M&A BB Biotech Q3 2025 Nasdaq Biotech Index
PRESS RELEASE published on 10/28/2025 at 13:15, 1 year ago Edison issues report on BB Biotech (BION) Edison issues positive report on BB Biotech (BION) with strong Q325 results, outperforming its benchmark. Sector outlook remains favorable with M&A as key performance driver Edison M&A BB Biotech Outperforming Q325 Results
BRIEF published on 10/24/2025 at 07:05, 1 year ago BB Biotech AG Releases Interim Report Highlighting Significant Profit Increase Investment Company BB Biotech AG Interim Report Net Profit Increase Drug Developers
BRIEF published on 10/24/2025 at 07:05, 1 year ago BB Biotech's Q3 2025 Outperformance Amid Sector Recovery Sector Recovery BB Biotech Q3 2025 Performance Nasdaq Biotechnology Index RNA-based Therapeutics
PRESS RELEASE published on 10/24/2025 at 07:00, 1 year ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/24/2025 at 07:00, 1 year ago BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
Published on 11/06/2026 at 13:00, 6 hours 41 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 7 hours 11 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 7 hours 11 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 14 hours 26 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 19:15, 26 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 41 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 1 hour 9 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 1 hour 41 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 17:41, 2 hours ago Turkiye Garanti Bankasi A.S.: Daily Share Buyback Transactions
Published on 11/06/2026 at 18:00, 1 hour 41 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 1 hour 47 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 2 hours 6 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
